Joseph Robert Berger MD

PubMed

• The Evolution of Anti-CD20 Treatment for Multiple Sclerosis: Optimization of Antibody Characteristics and Function.
  Bruce A C Cree, Joseph R Berger, Benjamin Greenberg
  CNS Drugs. 2025-04-03
• Parkinsonism Associated with Anti-B-Cell Maturation Antigen Chimeric Antigen Receptor T-Cell Therapy.
  Sabine Schneider, Whitley W Aamodt, Amy A Pruitt, Joseph R Berger
  Movement Disorders Clinical Practice. 2024-12-01
• Ideomotor Apraxia and "Milky Way" Sign in Progressive Multifocal Leukoencephalopathy.
  Robert S Eisinger, Felipe J Jones, Emily Ling-Lin Pai, Denise J Xu, Joseph R Berger
  Neurology. 2024-11-26

Journal Articles

• Treatment and diagnostic accuracy of neurosyphilis at Boston City Hospital's neurological unit, 1930-1979  
  J Neurol Sci, 1/1/2012
• Isolated Histoplasma capsulatum meningoencephalitis in an immunocompetent child  
  J Child Neurol, 1/1/2012
• No effect of disease modifying drugs on JC virus expression in multiple sclerosis  
  J Neurovirol, 1/1/2012
• Progressive multifocal leukoencephalopathy (PML) in a patient with Hodgkin's lymphoma treated with brentuximab vedotin  
  Leuk Lymphoma, 1/1/2012
• Moyamoya: another MS mimic  
  Multiple Sclerosis and Related 
Disorders, 1/1/2012
• NeuroAIDS in the developing world  
  Neurology, 1/1/2012
• The neuro-ophthalmology of HIV/AIDS  
  Neurobehavioral HIV Medicine, 1/1/2012
• Neurological infectious complications of immunosuppressive and immunomodulatory therapy in neurological diseases  
  Curr Treat Options Neurol, 1/1/2012
• Treatment related PML: perils and risk mitigation  
  Therap Adv Drug Safety, 1/1/2012
• Spotting MS mimics  
  Future Neurology, 1/1/2012
• Symptom management and improving quality of life in patients with multiple sclerosis  
  Current Medical Literature, 1/1/2012
• Case definitions for PML: a step in the right direction  
  J Neurol Neurosurg Psychiatr, 1/1/2012
• The interface of infectious disease and neuro-ophthalmology  
  J Neuro-ophthalmol, 1/1/2012
• Therapie der Multiplen Sklerose mit monokonalen Antikorpen: aktualisierte Empfelungen im Rahmen eines Expertenmeetings  
  Actuelle Neurologie, 1/1/2011
• Role of CD4+ and CD8+ T-Cell Responses Against JC Virus in the Outcome of Patients with Progressive Multifocal Leukoencephalopathy (PML) and PML-IRIS  
  J Virol, 1/1/2011
• An innovative approach for calculating work relative value units of clinical activities otherwise concealed  
  Acad Med, 1/1/2011
• The changing landscape of progressive multifocal leukoencephalopathy  
  Curr Infect Dis Rep, 1/1/2011
• Modeling PML Pathogenesis  
  Curr Opin Neurol, 1/1/2011
• Functional improvement and symptom management in multiple sclerosis: clinical efficacy of current therapies  
  Amer J Managed Care, 1/1/2011
• Contralateral optic neuritis following silicone oil endotamponade for retinal detachement  
  J Neurol Neurophysiol, 1/1/2011
• Delayed fingolimod-associated asystole  
  Multiple Sclerosis, 1/1/2011
• The clinical features of PML  
  Cleveland Clin J Med, 1/1/2011
• Neurosyphilis and the spinal cord - then and now  
  J Nerv Ment Dis, 1/1/2011
• The pathogenesis of progressive multifocal leukoencephalopathy  
  Discovery Medicine, 1/1/2011
• Too much of a good thing? IRIS with natalizumab associated PML  
  Neurology, 1/1/2011
• Join now to see all

Books/Book Chapters

• Neurologia 
  Chapter: Complicaciones neurologica del syndrome de inmunodeficiend cia n
adquirida 
  Editors: Gomez JT, Sanz MY and Sanchez EP.Manual Moderno, Bogota, ColumbiaEdition 2nd,2010
• Clinical Neurotoxicology 
  Chapter: Thermal Injury of the Nervous System 
  Editors: Dobbs M.Elsevier, Philadelphia, PA2009
• Neurologic Therapeutics: Principles and Practice 
  Chapter: Immunodeficiency diseases 
  Page 1540 - 1558Editors: Noseworthy JH.Martin Dunitz, London, UK2008
• NeuroAIDS Disorders: Pathophysiology, Diagnosis, and Treatment 
  Chapter: Neurosyphilis in AIDS 
  Page 363 - 373Editors: Goodkin K.ASM Press, Washington, DC2008
• Handbook of Clinical Neurology 
  Chapter: HIV/AIDS and the Nervous System 
  Editors: Vinkey PJ, Bruyn G.Elsevier, Amsterdam2007
• Vinken and Bruyn's Handbook of Clinical Neurology 
  Chapter: HIV/AIDS andrdthe Nervous System 
  Editors: Portegies P, Berger JR.Elsevier, Amsterdam, Holland2007
• Interface of Neurology and Internal Medicine 
  Chapter: Syphilis 
  Page 598 - 603Editors: Biller J.Lippincott Willliams and Wilkins, Philadelphia, PA2007
• Neuro-AIDS 
  Chapter: Drug abuse and Neuro-AIDS 
  Page 81 - 100Editors: Minagar A, Shapshak P.Nova Science Publisher, Inc, NY2006
• Neurologic Therapeutics:Principles and Practice 
  Chapter: Immunodeficiency diseases (Chapter 131) 
  Editors: Noseworthy JH.Martin Dunitz, London, UK2006
• Adult Neurology 
  Chapter: Coma 
  Page 192 - 206Editors: Corey-Bloom J.Balckwell Publishing, Ltd, Malden, MAEdition 2nd,2005
• Cecil's Textbook of Internal Medicine 
  Chapter: Poliomyelitis 
  Editors: Goldman L, Bennett JC.W.B. Sunders, Philadelphia, PAEdition 22nd,2004
• Cecil's Textbook of Internal Medicine 
  Chapter: Approach to viral infections of the nervous system 
  Editors: Goldman L, Bennett JC.W.B. Sunders, Philadelphia, PAEdition 22nd,2004
• Medlink Neurology 
  Chapter: Cat-scratch disease 
  Editors: Goldstein GW, Waxman SG, Gilman S.Arbor Publications, La Jolla, CA2004
• Neurologic Therapeutics:Principles and Practice 
  Chapter: Immunodeficiency diseases (Chapter 130) 
  Editors: Noseworthy JH.Martin Dunitz, London, UK2003
• Clinical Neurovirology 
  Chapter: Neuropathogenesis of viral infections 
  Page 21 - 34Editors: Nath A and Berger JR.Marcel Dekker, New York, NY2003
• Clinical Neurovirology 
  Chapter: Von Economo's encephalitis 
  Page 523 - 542Editors: Nath A and Berger JR.Marcel Dekker, New York, NY2003
• Clinical Neurovirology 
  Chapter: Neurological complications of antiviral vaccines 
  Page 593 - 602Editors: Nath A and Berger JR.Marcel Dekker, New York, NY2003
• Clinical Neurovirology 
  Chapter: HIV meningitis and dementia 
  Page 251 - 276Editors: Nath A and Berger JR.Marcel Dekker, New York, NY2003
• Clinical Neurovirology 
  Chapter: Progressive Multifocal Leukoencephalopathy 
  Page 223 - 249Editors: Nath A and Berger JR.Marcel Dekker, New York, NY2003
• The Encyclopedia of Neurological Sciences 
  Chapter: Progressive Multifocal Leukoencephalopathy 
  Page 65 - 69Editors: Tyler K, Aminoff M, Daroff RB.Academic Press, San Diego, CA2003
• The Encyclopedia of Neurological Sciences 
  Chapter: Neurosyphilis 
  Page 529 - 599Editors: Ross K, Aminoff M, Daroff RB.Academic Press, San Diego, CA2003
• Textbook of Neurological Surgery: Principles and Practice 
  Chapter: Tuberculosis of the Nervous System 
  Editors: Batjer H, Loftus C.Lippincott, Williams & Wilkins, Philadelphia, PA2003
• Clinical Neurovirology 
  Marcel Dekker, New York, NY2003
• Current Treatment Options in Infectious Diseases 
  Chapter: Neurosyphilis 
  Page 64 - 79Editors: Nath A, Gross.Current Science Inc, Philadelphia, PA2002
• Current Therapy in Neurological Diseases 
  Chapter: Fungal diseases 
  Page 146 - 151Editors: Johnson RT, Griffin JW, McArthur JC.CV Mosby, St. Louis, MOEdition 6th,2002
• Join now to see all

Abstracts/Posters

• Substantia nigra depigmetation, Parkinsonism and birth cohort: remote effect of encephalitis lethargic?
  Annual Meeting of the American Academy of Neurology, New Orleans, LA, 1/26/2012
• Substantia nigra depigmentation, Parkinsonism and birth cohort: remote effect of encephalitis lethargic?
  64th American Academy of Neurology, San Diego, CA, 1/26/2012
• Vedolizumab does not reduce the CD4+:CD8+ ratio in the CSF of healthy volunteers
  7th Annual Congress of European Crohn's and Colitis Organization, Barcelona, Spain, 1/16/2012
• Vedolizumab does not reduce the CD4+:CD8+ ratio in the CSF of healthy volunteers
  19th United European Gastroenterology Week, Stockholm, Sweden, 1/22/2011
• Absence of effect on JC virus expression of disease modifying drugs
  25th Annual Consortium of MS Centers Meeting, Montreal, Canada, 1/2/2011
• Fatigue as a precursor to clinically definite multiple sclerosis
  25th Annual Consortium of MS Centers Meeting, Montreal, Canada, 1/2/2011
• Vedolizumab does not reduce the CD4+:CD8+ ratio in the CSF of healthy volunteers
  Advances in Inflammatory Bowel Diseases Crohn's & Colitis Foundation's Clinical and Research Conference, Hollywood, FL, 1/1/2011
• Absence of effect on JC virus expression by disease modifying drugs
  Consortium of MS Centers, Montreal, Canada, 1/1/2011
• Fatigue as a precursor to clinically definite multiple sclerosis
  Consortium of MS Centers, Montreal, Canada, 1/1/2011
• Cerebral toxoplasmosis following natalizumab treatment in multiple sclerosis
  Consortium of MS Centers, Montreal, Canada, 1/1/2011
• No increase in JC viremia, lymphocyte count or circulating CD34+ hematopoietic progenitor cells afterthtreatment with vedolizumab, a humanized monoclonal antibody to 4...
  United European 
Gastroenterology Week, Barcelona, Spain, 1/23/2010
• Role of CD4+ and CD8+ T cell responsis against JC virus in patients with PML
  10th International Symposium of NeuroVirology, Milan, Italy, 1/12/2010
• No association between vedolizumab exposure and JC virus levels
  2010 Advances in Inflammatory Bowel Diseases, Crohn's & Colitis Foundation's Clinical & Research Conference, Hollywood, FL, 1/9/2010
• Neurological complications of influenza viruses: the role of dysregulation of immune system
  Neurology, 1/1/2010
• No increase in JC viremia, lymphocyte count or circulating CD34+ hematopoietic progenitor cells after treatment with vedolizumab, a humanized monoclonal antibody to 4 ...
  Digestive Disease Week, Memorial Convention Center, New Orleans, LA, 1/1/2010
• Neurological complications of influenza viruses: the rold of dysregulation of immune system
  Neurology, 1/1/2010
• Autoimmune disorders associated with carbon monoxide poisoning
  61st Annual Meeting American Academy of Neurology, Seattle, WA, 1/29/2009
• JC virus expression is unaltered by interferon-beta or glatiramer acetate(T-7)
  Annual Meeting of American Neurological Association, Baltimore, MD, 1/12/2009
• Concurrent diagnosis of multiple sclerosis and HIV infection in U.S. military veterans (T-24)
  Annual Meeting of American Neurological Association, Baltimore, MD, 1/12/2009
• Subtle abnormalities of the white matter of relapsing-remitting MS patients and the response to interferon B (Betaseron): A pilot study
  23rd Congress of ECTRIMS, Prague, Czech Republic, 1/11/2007
• PML in the setting of monoclonal antibody therapies for multiple scherosis
  IV International Polyomaviruses and Human Disease Meeting, Barcelona, Spain, 1/3/2007
• nterplay of host and viral factorths in the clinical outcome of patients with progressive multifocal leukoencephalopathy (PML)
  8th International Symposium on Neurovirology, J Neurovirol, 1/1/2007
• MR abnormalities in normal appearing white matter and the response to interferon beta 1b: a pilot study
  Multiple Sclerosis, 1/1/2007
• Controlled Study of High- concentration capsaicin patch for painful HIV-associated distal sensory polyneuropathy
  13th Conference on Retroviruses and Opportunistic Infections, 1/5/2006
• Primary lateral sclerosis with HIV-1 infection: report of two cases and review of HIV-associated motor neuron diseases
  11th International Congress on neuromuscular Diseases (ICNMD) 2006, Lufti Convention Center, Istanbul, Turkey, 1/2/2006
• Join now to see all

Lectures

• Challenges for Chairs in Neurology 
  San Diego, CA - 1/22/2012
• Disorders of Nerve Roots and Plexi 
  New Orleans, LA - 1/22/2012
• MS Mimics 
  New Orleans, LA - 1/21/2012
• Fungal meningitis 
  Mumbai, India - 1/6/2012
• Brain abscess 
  Mumbai, India - 1/6/2012
• HIV related meninigitis 
  Mumbai, India - 1/6/2012
• Infectious myelopathies 
  Mumbai, India - 1/6/2012
• Neurological Complications of HIV 
  Providence Health System, Portland, OR - 1/31/2011
• PML in the Biologic Era 
  Cleveland Clinic, Cleveland, OH - 1/30/2011
• Neurological Complications in the age of Highly Active Retroviral Therapies 
  Vanderbilt University - 1/15/2011
• Update on Neurological Infectious Disease 
  Honolulu, HI - 1/11/2011
• Progressive Multifocal Leukoencephalopathy in the Era of Monoclonals 
  University of Kentucky - 1/2/2011
• Clinical manifestations, diagnosis andthtreatment of PML 
  Mannheim, Germany - 1/24/2010
• Jakob-Creutzfeldt Disease 
  University of Kentucky - 1/15/2010
• Fungal Meningitides 
  Amman, Jordan - 1/7/2010
• Multiple Sclerosis Treatments-Anticipating the Risks of Future Therapies 
  San Antonio, TX - 1/3/2010
• Von Economo's Encephalitis 
  Black Lion's Hospital, Addis Abba, Ethiopia - 1/1/2010
• Overview and Clinical Perspective of PML and Biology of the JC Virus 
  New York, NY - 1/10/2009
• HIV Dementia-Past, present and future 
  University of Kentucky - 1/7/2009
• Von Economo's Encephalitis-Revisited. Should We Worry about its Reappearance with the H1N1 Pandemic? 
  University of Kentucky - 1/1/2009
• Controversies in Infectious Disease 
  Seattle, WA - 1/1/2009
• Progressive Multifocal Leukoencephalopathy: A review and Role of Newer Monoclonal Antibody Therapies in its Pathogenesis. What every Physician needs to Know Who Prescr... 
  University of Kentucky - 1/23/2008
• The Neurological Complications of HSV-2 
  University of Kentucky - 1/17/2007
• Progressive Multifocal Leukoencephalopathy and Tysabri 
  Scottsdale, AZ - 1/31/2006
• Challenging Neuro-Infectious Cases 
  Miami, FL - 1/25/2006
• Join now to see all

Other

• Infectious myelopathies 
  Continuum Spinal Cord, Root and Plexus Disorders
  1/1/2011
• Comment on JC virus reactivation with natalizumab 
  J Watch Neurology
  1/1/2009
• Chronic Progressive Cervical Myelopathy with HTLV-1 Infection 
  Journal Watch Neurology
  1/1/2004
• More evidence linking HIV infection with stroke and TIA 
  Journal Watch Neurology
  1/31/2003
• Human polyovirus JCV and CNS neoplasia-culprit or innocent bystander? 
  International Society of Neurovirology Newsletter
  1/1/2002
• Reversible ALS-like disorder in HIV infection. Review 
  Journal Watch Neurology
  1/1/2001
• Central nervous system opportunistic infections 
  Neurology Network Commentary
  1/1/2000
• Commentary; Plasma viral load and CD4 lymphocytes predict HV-associated dementia and sensory neuropathy 
  Journal Watch Neurology
  1/1/1999
• A refined and focused neurological examination for the patient with AIDS 
  HIV Neurology Newsletter Summer
  1/1/1999
• Commentary on Hsich G., Kenney K, Gibbs CJ Jr, Lee KH, Harrington MG: The 14-3-3 Brain Protein in Cerebrospinal Fluid as a Marker for Transmissible Spongiform Encephal... 
  N Eng J Med in Neurology Network Commentary
  1/1/1997
• Handbook for Creutzfeldt-Jakob disease 
  The Creutzfeldt- Jakob Disease Foundation
  Miami, FL - 1/1/1996
• Progressive multifocal leukoencephalopathy 
  HIV: Advances in Research and Therapy
  Cliggott Communictions, Greenwich, CT - 1/1/1996
• A new drug for Alzheimer's 
  Miami Health Letter
  1/1/1994
• Tuberculous meningitis 
  Current Opinions in Neurology
  1/1/1994
• Distinguishing PML from HIV dementia 
  HIV Newsline
  NY - 1/1/1994
• Neurological complications of HIV disease. A standards of practice report 
  Physicians Association for AIDS Care. PAAC Notes
  Chicago, IL - 1/1/1992
• The neurology of AIDS 
  Clinical Review Neurology
  1/1/1991
• Differentiating stroke: a case studies primer 
  Emergency Medicine
  1/1/1991
• Iatrogenic neurology 
  Weekly Update in Neurology and Neurosurgery
  1/1/1991
• The neurological complications of human immunodeficiency virus 
  Weekly Update in Neurology and Neurosurgery
  1/1/1988
• The neurological complications of the acquired immune deficiency syndrome 
  Weekly Update in Neurology and Neurosurgery
  1/1/1984
• What the patient should know about Parkinson's Disease 
  National Parkinsons Disease Foundation, Inc
  Miami, FL - 1/1/1983
• Join now to see all